The adaptive aerosol delivery system in a telehealth setting: Patient acceptance, performance and feasibility

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 23, Issue SUPPL. 1, 2010, Pages

  Nikander, Kurt ^a   Denyer, John ^b   Dodd, Mary ^c   Dyche, Tony ^b   Webb, Kevin ^c   Weller, Peter ^d   Stableforth, David ^e  

^a PHILIPS HEALTHCARE   (United States)

^b Respiratory Drug Delivery UK Ltd   (United Kingdom)

^c WYTHENSHAWE HOSPITAL   (United Kingdom)

^d BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^e BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

Adaptive aerosol delivery (AAD) system; Colistin; Cystic fibrosis; Nebulizer; Questionnaire; Telehealth

Indexed keywords

ADAPTIVE AEROSOL DELIVERY SYSTEM; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DEVICE; DRUG DELIVERY SYSTEM; FEASIBILITY STUDY; FEMALE; HUMAN; MALE; MEDICAL TECHNOLOGY; PATIENT ATTITUDE; PERCEPTION; PERFORMANCE; TELEHEALTH;

ADMINISTRATION, INHALATION; ADULT; AEROSOLS; CHILD; CYSTIC FIBROSIS; DRUG DELIVERY SYSTEMS; FEMALE; HOME CARE SERVICES; HUMANS; MALE; NEBULIZERS AND VAPORIZERS; PATIENT ACCEPTANCE OF HEALTH CARE; PHARMACEUTICAL PREPARATIONS; QUESTIONNAIRES; TECHNOLOGY, PHARMACEUTICAL; TELEMEDICINE;

EID: 77950599486     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2009.0770     Document Type: Article

References (12)

1. Wuorenma JK: Tele-What?: it's time to re-think the industry's terms. Telehealth World. 2008;3:7.
2. Pagliari C, Sloan D, Gregor P, Sullivan F, Detmer D, Kahan JP, Oortwijn W, and MacGillivray S: What is eHealth (4): a scoping exercise to map the field. J Med Internet Res. 2005;7:1-19.
3. Rasmussen LM, Phanareth K, Nolte H, and Backer V: Internet-based monitoring of asthma: a long-term, randomized clinical study of 300 asthmatic subjects. J Allergy Clin Immunol. 2005;115:1137-1142.
4. Bynum A, Hopkins D, Thomas A, Copeland N, and Irwin C: The effect of telepharmacy counseling on metered-dose inhaler technique among adolescents with asthma in rural Arkansas. Telemed J E-Health. 2001;3:207-217.
5. Magrabi F, Lovell NH, Henry RL, and Celler BG: Designing home telecare: a case study in monitoring cystic fibrosis. Telemed J E-Health. 2005;6:707-719.
6. Doring G, and Hojby N: Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. J Cyst Fibros. 2004;3:67-91.
7. Flume PA, O'Sullivan BP, Robinson KA, Goss CH, Mogayzel PJ Jr, Willey-Courand DB, Bujan J, Finder J, Lester M, Quittell L, Rosenblatt R, Vender RL, Hazle L, Sabadosa K, and Marshall B: Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2007;176:957-969.
8. Nikander K. Adaptive aerosol delivery: the principles. Eur Respir Rev. 1997;7:385-387.
9. Denyer J: Adaptive aerosol delivery in practice. Eur Respir Rev. 1997;7:388-389.
10. Nikander K, Arheden L, Denyer J, and Cobos N: Parents' adherence with nebulizer treatment of their children when using an Adaptive Aerosol Delivery (AAD) system. J Aerosol Med. 2003;16:273-281.
11. Denyer J, Nikander K, and Smith NJ: Adaptive Aerosol Delivery (AAD) technology. Expert Opin Drug Deliv. 2004;1:165-176.
12. Van Dyke R, and Nikander K: Delivery of iloprost inhalation solution with HaloLite, Prodose, and I-neb Adaptive Aerosol Delivery (AAD) systems-an in vitro study. Respir Care. 2007;52:184-190.